1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Sweden Tackles Regulatory Barriers To Decentralized Trials

MPA Offers Free Advice On The Dos And Don’ts Of Virtual Trials

 
• By Vibha Sharma

The COVID-19 pandemic has given a new impetus to Sweden’s ongoing efforts to support decentralized clinical trials. 

Online tele medicine isometric concept. Medical consultation and treatment via application of smartphone connected internet clinic.
Decentralized Trials Have Emerged As A Critical Tool In Pharma’s Pursuit To Improve Patient Experience • Source: Alamy

Sweden’s Medical Products Agency is offering companies free advice on decentralized clinical trials until the end of this year as part of an ongoing project to investigate possible regulatory hurdles to using digital technology in trials.

The project, which started at the beginning of 2020, is now in its final stages and is no longer accepting studies. However, the MPA said it was continuing to offer...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

US FDA’s Prasad: ‘We Will Always Embrace Surrogate Endpoints’

 
• By Sarah Karlin-Smith

The new CBER director, once best known in the pharma world for criticizing accelerated approval, committed to expediting cancer drugs with surrogate endpoints.

UK And US Regulators In Sync On RWD External Control Arms

 
• By Vibha Sharma

The UK regulator’s draft guideline on the use of external control arms based on real-world data reflects concepts similar to those outlined by the US Food and Drug Administration.

EU To Track Decentralized Clinical Trials In CTIS To Support Innovation

 
• By Vibha Sharma

Monitoring the use of decentralized elements in clinical trials is a priority for the European medicines regulatory network.

More from R&D

EU To Track Decentralized Clinical Trials In CTIS To Support Innovation

 
• By Vibha Sharma

Monitoring the use of decentralized elements in clinical trials is a priority for the European medicines regulatory network.

Pink Sheet Podcast: US FDA’s Big Vaccine Policy Week

 
• By Derrick Gingery, Sarah Karlin-Smith, Sue Sutter, and Nielsen Hobbs

Pink Sheet reporter and editors discuss the new clinical trial requirements that the FDA announced for COVID-19 vaccines, the updated label for Novavax’s newly approved COVID-19 vaccine, and other vaccine-related events that were part of a busy week for policy in the sector.

ICH Targets RWE, Rare Diseases, Biosimilars, ATMPs In New Guideline Push

 
• By Vibha Sharma

The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.